|

Ramantamig Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since September 2026

Also known as: BCMAxGPRC5DxCD3, JNJ-79635322

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Janssen Research & Development, LLC3

Indications

  • Multiple Myeloma3
  • Cancer3
  • Relapse Multiple Myeloma1
  • Refractory Multiple Myeloma1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.